FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
1. Medtronic announces FDA clearance for MiniMed™ 780G's SmartGuard™ algorithm. 2. MiniMed™ 780G system approved for adults with insulin-requiring type 2 diabetes. 3. Integration with Abbott's Instinct sensor enhances diabetes management technology. 4. Clinical trials show significant improvement in glycemic outcomes using MiniMed™ 780G. 5. Regulatory process completion expected to commence customer pre-orders soon.